Blue Star Foods Enters into Supply Agreement for Up to $4 Million Annually with Just Food For Dogs
31 janv. 2023 08h30 HE
|
Blue Star Foods Corp.
Will Supply Wild Caught Cod as Ingredient for its Gourmet Dog Food Miami, FL, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ:...
Pfizer und BioNTech schließen neue Liefervereinbarung mit der US-Regierung für zusätzliche Dosen des COVID-19-Impfstoffs
29 juin 2022 16h45 HE
|
BioNTech SE
Liefervereinbarung umfasst 105 Millionen 30 µg-, 10 µg- sowie 3 µg-Dosen, die bis einschließlich des vierten Quartals 2022 geliefert werden sollen; die US-Regierung hat die Option, 195 Millionen...
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
29 juin 2022 16h45 HE
|
BioNTech SE
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses NEW YORK and MAINZ, GERMANY, JUNE...
Optimi Health Finalizes Partnership and Psilocybin Supply Agreement With ATMA Journey Centers
08 juin 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 08, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Enters Into Psilocybin Supply Agreement With Filament Health
31 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc.
27 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
AXIM Biotech Announces New Milestones in Preparation of Dry Eye Disease Diagnostics Launch
15 févr. 2022 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
AXIM is driven to positively transform the state of Dry Eye Disease (DED) testing and diagnosis The company will deploy industry leader IUL’s state-of-the-art iPeak readers Company Adds Veteran Lab...
Pfizer und BioNTech beliefern U.S.-Regierung mit 50 Millionen weiteren Kinderimpfdosen des COVID-19-Impfstoffs zur Vorbereitung auf zukünftigen Bedarf
28 oct. 2021 06h58 HE
|
BioNTech SE
Impfdosen werden vermutlich bis April 2022 geliefert NEW YORK und MAINZ, Deutschland, 28. Oktober 2021 — Pfizer Inc. (NYSE: PFE, “Pfizer”) und BioNTech SE (Nasdaq: BNTX, “BioNTech”) gaben heute...
Pfizer And BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
28 oct. 2021 06h58 HE
|
BioNTech SE
Doses expected to be delivered by April 2022 NEW YORK and MAINZ, GERMANY, October 28, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has...
Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
23 juil. 2021 06h45 HE
|
BioNTech SE
Dose deliveries for new order expected to occur from October 2021 through April 2022 NEW YORK AND MAINZ, GERMANY, July 23, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX)...